Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease

NCT06856681 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped sponsor decision to cancel project before enrollment.

Conditions

Alzheimers Disease

Interventions

DIAGNOSTIC_TEST: PrecivityAD2 - Early Testing
DIAGNOSTIC_TEST: PrecivityAD2 - Delayed Testing

Sponsor

C2N Diagnostics

Collaborators

Alzheimer's Association